-
-
Chronic kidney disease: towards a risk-based approach.
-
The Role of Risk Prediction Models in Prevention and Management of AKI.
Author(s) pre or post print version only
-
Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study.
-
13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups.
Author(s) Pre or Post Print Version Only
-
Patients With Severe Alcoholic Hepatitis Given Prednisolone Therapy Who Have High Circulating Levels Of Bacterial DNA are at Increased Risk for Developing Infections.
Author(s) Pre or Post Print Version Only
-
Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3.
Author(s) Post Print Version Only
-
Risk of statin-induced rhabdomyolysis in patients with hepatic impairment.
-
Risk profile in chronic kidney disease stage 3: older versus younger patients.
-
Intervention planning for the REDUCE maintenance intervention: a digital intervention to reduce reulceration risk among patients with a history of diabetic foot ulcers.
-
High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients.
Author(s) Pre Print Only
-
Progress in risk prediction for people with chronic kidney disease.
Author(s) Pre Print Version Only
-
Risk Prediction for Acute Kidney Injury in Acute Medical Admissions in the UK.
Author(s) Pre or Post Print Version Only
-
Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3.
-
The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis
-
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
-
Early onset type 2 diabetes: risk factors, clinical impact and management.
-
Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients--analysis based on the National Lung Cancer Audit.